Role of metabolic surgery in remission of type 2 diabetes mellitus in patients with obesity
Open Access
- 10 May 2023
- journal article
- Published by Focus Endocrinology in FOCUS. Endocrinology
- Vol. 4 (2) , 69-74
Abstract
Type 2 diabetes mellitus and obesity are two socially significant diseases, the prevalence of which has now assumed pandemic proportions. Obesity, as a rule, precedes the development of type 2 diabetes, being the most powerful risk factor for the development of this disease. In patients with obesity and type 2 diabetes with a BMI >35 kg/m2, bariatric surgery is recommended if glycemic control cannot be achieved after several attempts at non-surgical treatment of obesity. There is no doubt the effectiveness of bariatric surgery not only in the treatment of obesity, but also in achieving remission of type 2 diabetes. It seems relevant to study the predictors of achieving remission of type 2 diabetes, as well as factors that can worsen the prognosis. The purpose of the review: to study the effectiveness of metabolic surgery in achieving remission of type 2 DM, as well as predictors of remission of type 2 DM in obese patients after bariatric surgery.Keywords
This publication has 18 references indexed in Scilit:
- The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)Diabetes mellitus, 2016
- Determinants of Diabetes Remission and Glycemic Control After Bariatric SurgeryDiabetes Care, 2015
- Insulin Cessation and Diabetes Remission After Bariatric Surgery in Adults With Insulin-Treated Type 2 DiabetesDiabetes Care, 2015
- Predictive Factors of Type 2 Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysisObesity Surgery, 2014
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular ComplicationsJAMA, 2014
- Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild ObesityDiabetes Care, 2012
- C-peptide Predicts the Remission of Type 2 Diabetes After Bariatric SurgeryObesity Surgery, 2011
- Bariatric surgery: an IDF statement for obese Type 2 diabetesDiabetic Medicine, 2011
- Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?Obesity Surgery, 2008
- United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet TherapyAnnals of Internal Medicine, 1998